• Please log in or register to access this feature.

Research Article

You have open access to this content

ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium

  1. Daniel G. Holland1,2,
  2. Angela Burleigh3,4,
  3. Anna Git1,2,
  4. Mae A. Goldgraben1,2,
  5. Pedro A. Perez-Mancera1,2,
  6. Suet-Feung Chin1,
  7. Antonio Hurtado1,
  8. Alejandra Bruna1,2,
  9. H. Raza Ali1,2,
  10. Wendy Greenwood1,2,
  11. Mark J. Dunning1,
  12. Shamith Samarajiwa1,
  13. Suraj Menon1,
  14. Oscar M. Rueda1,2,
  15. Andy G. Lynch1,
  16. Steven McKinney3,4,
  17. Ian O. Ellis5,
  18. Connie J. Eaves3,4,
  19. Jason S. Carroll1,2,
  20. Christina Curtis1,8,
  21. Samuel Aparicio3,4,
  22. Carlos Caldas1,2,6,7,*

Article first published online: 18 FEB 2011

DOI: 10.1002/emmm.201100122

Issue

EMBO Molecular Medicine

EMBO Molecular Medicine

Volume 3, Issue 3, pages 167–180, March 2011

Additional Information

How to Cite

Holland, D. G., Burleigh, A., Git, A., Goldgraben, M. A., Perez-Mancera, P. A., Chin, S.-F., Hurtado, A., Bruna, A., Ali, H. R., Greenwood, W., Dunning, M. J., Samarajiwa, S., Menon, S., Rueda, O. M., Lynch, A. G., McKinney, S., Ellis, I. O., Eaves, C. J., Carroll, J. S., Curtis, C., Aparicio, S. and Caldas, C. (2011), ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium. EMBO Mol Med, 3: 167–180. doi: 10.1002/emmm.201100122

Author Information

  1. 1

    Cancer Research UK, Cambridge Research Institute, Cambridge, UK

  2. 2

    Department of Oncology, University of Cambridge, Li Ka Shing Centre, Cambridge, UK

  3. 3

    Department of Pathology, University of British Columbia, Vancouver, Canada

  4. 4

    BC Cancer Agency, Vancouver, Canada

  5. 5

    Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK

  6. 6

    NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

  7. 7

    Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

  8. 8

    Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angles, California

*Tel: +44 1223404420, Fax: +44 1223404422

Publication History

  1. Issue published online: 1 MAR 2011
  2. Article first published online: 18 FEB 2011
  3. Accepted manuscript online: 31 JAN 2011 06:31AM EST
  4. Manuscript Accepted: 18 JAN 2011
  5. Manuscript Revised: 16 JAN 2011
  6. Manuscript Received: 16 AUG 2010

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (1287K)

References

  • Adelaide J, Finetti P, Bekhouche I, Repellini L, Geneix J, Sircoulomb F, Charafe-Jauffret E, Cervera N, Desplans J, Parzy D, et al (2007) Integrated profiling of basal and luminal breast cancers. Cancer Res 67: 11565- 11575
  • Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ, Barbosa-Morais NL, Teschendorff AE, Green AR, Ellis IO, et al (2007) MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 8: R214
  • Brown JD, Dutta S, Bharti K, Bonner RF, Munson PJ, Dawid IB, Akhtar AL, Onojafe IF, Alur RP, Gross JM, et al (2009) Expression profiling during ocular development identifies 2 Nlz genes with a critical role in optic fissure closure. Proc Natl Acad Sci USA 106: 1462- 1467
  • Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo WL, Lapuk A, Neve RM, Qian Z, Ryder T, et al (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10: 529- 541
  • Chin SF, Teschendorff AE, Marioni JC, Wang Y, Barbosa-Morais NL, Thorne NP, Costa JL, Pinder SE, van de Wiel MA, Green AR, et al (2007) High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biol 8: R215
  • Dorfman R, Glazer L, Weihe U, Wernet MF, Shilo BZ (2002) Elbow and Noc define a family of zinc finger proteins controlling morphogenesis of specific tracheal branches. Development 129: 3585- 3596
  • Eirew P, Stingl J, Raouf A, Turashvili G, Aparicio S, Emerman JT, Eaves CJ (2008) A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat Med 14: 1384- 1389
  • Garcia MJ, Pole JC, Chin SF, Teschendorff A, Naderi A, Ozdag H, Vias M, Kranjac T, Subkhankulova T, Paish C, et al (2005) A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes. Oncogene 24: 5235- 5245
  • Gelsi-Boyer V, Orsetti B, Cervera N, Finetti P, Sircoulomb F, Rouge C, Lasorsa L, Letessier A, Ginestier C, Monville F, et al (2005) Comprehensive profiling of 8p11-12 amplification in breast cancer. Mol Cancer Res 3: 655- 667
  • Goldfarb M, Shimizu K, Perucho M, Wigler M (1982) Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells. Nature 296: 404- 409
  • Haverty PM, Fridlyand J, Li L, Getz G, Beroukhim R, Lohr S, Wu TD, Cavet G, Zhang Z, Chant J (2008) High-resolution genomic and expression analyses of copy number alterations in breast tumors. Genes Chromosomes Cancer 47: 530- 542
    Direct Link:
  • Horikawa I, Cable PL, Mazur SJ, Appella E, Afshari CA, Barrett JC (2002) Downstream E-box-mediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: evidence for an endogenous mechanism of transcriptional repression. Mol Biol Cell 13: 2585- 2597
  • Hoyle J, Tang YP, Wiellette EL, Wardle FC, Sive H (2004) nlz gene family is required for hindbrain patterning in the zebrafish. Dev Dyn 229: 835- 846
    Direct Link:
  • Kwek SS, Roy R, Zhou H, Climent J, Martinez-Climent JA, Fridlyand J, Albertson DG (2009) Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis. Oncogene 28: 1892- 1903
  • Letessier A, Sircoulomb F, Ginestier C, Cervera N, Monville F, Gelsi-Boyer V, Esterni B, Geneix J, Finetti P, Zemmour C, et al (2006) Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers. BMC Cancer 6: 245
  • Lin CY, Vega VB, Thomsen JS, Zhang T, Kong SL, Xie M, Chiu KP, Lipovich L, Barnett DH, Stossi F, et al (2007) Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet 3: e87
  • Nakamura M, Choe SK, Runko AP, Gardner PD, Sagerstrom CG (2008) Nlz1/Znf703 acts as a repressor of transcription. BMC Dev Biol 8: 108
  • Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, et al (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 27: 1160- 1167
  • Prentice LM, Shadeo A, Lestou VS, Miller MA, deLeeuw RJ, Makretsov N, Turbin D, Brown LA, Macpherson N, Yorida E, et al (2005) NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis. Oncogene 24: 7281- 7289
  • Raouf A, Zhao Y, To K, Stingl J, Delaney A, Barbara M, Iscove N, Jones S, McKinney S, Emerman J, et al (2008) Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell 3: 109- 118
  • Runko AP, Sagerstrom CG (2004) Isolation of nlz2 and characterization of essential domains in Nlz family proteins. J Biol Chem 279: 11917- 11925
  • Russnes HG, Vollan HK, Lingjaerde OC, Krasnitz A, Lundin P, Naume B, Sorlie T, Borgen E, Rye IH, Langerod A, et al (2010) Genomic architecture characterizes tumor progression paths and fate in breast cancer patients. Sci Transl Med 2: 38ra47
  • Santarius T, Shipley J, Brewer D, Stratton MR, Cooper CS (2010) A census of amplified and overexpressed human cancer genes. Nat Rev Cancer 10: 59- 64
  • Schmidt D, Wilson MD, Spyrou C, Brown GD, Hadfield J, Odom DT (2009) ChIP-seq: using high-throughput sequencing to discover protein–DNA interactions. Methods 48: 240- 248
  • Shih C, Weinberg RA (1982) Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell 29: 161- 169
  • Sircoulomb F, Nicolas N, Ferrari A, Finetti P, Bekhouche I, Rousselet E, Lonigro A, Adelaide J, Baudelet E, Esteyries S, et al (2011) ZNF703 gene amplification at 8p12 specifies luminal B breast cancer. Embo Mol Med DOI: 10.1002/emmm.201100121
  • Slorach EM, Chou J, Werb Z (2011) Zeppo1 is a novel metastasis promoter that represses E-cadherin expression and regulates p120-catenin isoform expression and localization. Genes Dev (in press)
  • Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100: 8418- 8423
  • Stampfer MR, Garbe J, Levine G, Lichtsteiner S, Vasserot AP, Yaswen P (2001) Expression of the telomerase catalytic subunit, hTERT, induces resistance to transforming growth factor beta growth inhibition in p16INK4A(−) human mammary epithelial cells. Proc Natl Acad Sci USA 98: 4498- 4503
  • Stingl J, Eaves CJ, Zandieh I, Emerman JT (2001) Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res Treat 67: 93- 109
  • Stingl J, Emerman JT, Eaves CJ (2005) Enzymatic dissociation and culture of normal human mammary tissue to detect progenitor activity. Methods Mol Biol 290: 249- 263
  • Turgeon D, Carrier JS, Levesque E, Hum DW, Belanger A (2001) Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 142: 778- 787
  • Welm BE, Dijkgraaf GJ, Bledau AS, Welm AL, Werb Z (2008) Lentiviral transduction of mammary stem cells for analysis of gene function during development and cancer. Cell Stem Cell 2: 90- 102
View Full Article with Supporting Information (HTML) Get PDF (1287K)